Krystal Biotech (KRYS) has been on the Compounding Healthcare “Bio Boom” speculative portfolio since the investing group’s inception due to their ability to develop cutting-edge “redosable” gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results